ArticleJCO global oncology2021

Real-World Outcomes With Generic Pomalidomide in Relapsed Refractory Multiple Myeloma-Experience From a Tertiary Care Cancer Center.

Suresh Kumar Bondili et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.